Targeting inflammation as a therapeutic strategy in accelerated atherosclerosis in rheumatoid arthritis.

Rheumatoid arthritis (RA) is an autoimmune disease affecting approximately 1% of the population. Patients have reduced life expectancy and the leading cause of death is cardiovascular disease (CVD), with patients experiencing at least a 2-fold increased risk of myocardial infarction. RA is recognize...

詳細記述

書誌詳細
主要な著者: Full, L, Monaco, C
フォーマット: Journal article
言語:English
出版事項: 2011